Europe · Markets & Finance · L'Agefi Suisse

IBSA inaugure l’extension d’un site de production en Italie

Published by L'Agefi Suisse · Switzerland 11 h ago

L’investissement de 13,5 millions d’euros doit porter la production annuelle de seringues préremplies d’acide hyaluronique de 6 à 14 millions d’unités.

Read the full article on L'Agefi Suisse Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (agefi.com)

Also worth reading

City A.M.

Are rolling stocks about to go off the rails?

Financial Times

Houthi rebels target Riyadh and Aden in new missile barrage

This is Money

Royal Mail to cut 2,500 jobs by the end of next year as part of sweeping organisational overhaul

FXStreet

Gold falls as US Dollar, Treasury yields rebound ahead of Fed Minutes

Reuters Markets

European shares, euro fall as energy shock, fiscal worries bite

Reuters Sustainability